MALCOLM BRENNER to Central Nervous System Neoplasms
This is a "connection" page, showing publications MALCOLM BRENNER has written about Central Nervous System Neoplasms.
Connection Strength
0.200
-
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors. J Clin Oncol. 2024 Aug 10; 42(23):2769-2779.
Score: 0.180
-
Escalating sequential high-dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors. Bone Marrow Transplant. 1992 Nov; 10(5):457-62.
Score: 0.020